| Trial ID: | L0918 |
| Source ID: | NCT01922830
|
| Associated Drug: |
Bio-25
|
| Title: |
Probiotics and Microbiota in Bariatric Surgery
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
NAFLD
|
| Interventions: |
Dietary Supplement: Bio-25 (Supherb);Dietary Supplement: Placebo (for Bio-25, Supherb)
|
| Outcome Measures: |
Hepato-Renal Index (HRI) method by abdominal USLiver fibrosis - by Fibroscan (transient elastography);Anthropometric measurements;Biochemical fasting blood tests;The fecal microbiota composition;Quality of life (QoL);Food tolerance after bariatric surgery;Liver MRI;Hand grip;Microbiome composition and function
|
| Sponsor/Collaborators: |
Tel-Aviv Sourasky Medical Center
|
| Gender: |
All
|
| Age: |
18 Years65 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
100
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
|
| Start Date: |
12/08/2013
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
Israel
|
| URL: |
https://clinicaltrials.gov/show/NCT01922830
|
